CDER unveils 30 new planned guidance documents in 2022 agenda
Posted 07 February 2022 | By Jeff Craven About one-third of the guidance documents in the US Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research (CDER)’s 2022 guidance...